Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation

Philadelphia, December 4, 2024 (PRNewswire) -- Dr. Vatsala Naageshwaran, an accomplished biopharmaceutical leader, has been appointed CEO of Franklin Biolabs. With over two decades of experience spanning biotech, CROs, and advanced therapies, she has a proven track record in building teams, driving business strategy, and supporting innovative therapeutic development. Her leadership is poised to propel Franklin Biolabs' mission to bring life-changing genetic medicines to patients.

Read full article here.